Generation of ES cells for conditional expression of nuclear receptors and coregulators in vivo.
Nuclear receptors and coregulators orchestrate diverse aspects of biological functions and inappropriate expression of these factors often associates with human diseases. The present study describes a conditional overexpression system consisting of a minigene located at the Rosa26 locus in the genome of mouse embryonic stem (ES) cells. Before activation, the minigene is silent due to a floxed STOP cassette inserted between the promoter and the transgene. Upon cre-mediated excision of the STOP cassette, the minigene constitutively expresses the tagged transgene driven by the ubiquitous CAGGS promoter. Thus, this system can be used to express target gene in any tissue in a spatial and/or temporal manner if respective cre mouse lines are available. Serving as proof of principle, the CAG-S-hCOUP-TFI allele was generated in ES cells and subsequently in mice. This allele was capable of conditionally overexpressing human chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in all tissues tested upon activation by cre drivers. This allele was further subjected to address functionality of expressed COUP-TFI and the functional similarity between COUP-TFI and COUP-TFII. Expression of COUP-TFI in COUP-TFII-ablated uterus suppressed aberrant estrogen receptor-alpha activities and rescued implantation and decidualization defects of COUP-TFII mutants, suggesting that COUP-TFI and COUP-TFII are able to functionally compensate for each other in the uterus. A toolbox currently under construction will contain ES cell lines for overexpressing all 48 nuclear receptors and selected 10 coregulators. Upon completion, it will be a very valuable resource for the scientific community. Several ES cells are currently available for distribution.
Wu
San-Pin
SP
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Lee
Dong-Kee
DK
Demayo
Francesco J
FJ
Tsai
Sophia Y
SY
Tsai
Ming-Jer
MJ
D000483:Alleles; D000818:Animals; D051838:COUP Transcription Factor I / Q000378:metabolism; D051837:COUP Transcription Factor II / Q000172:deficiency / Q000378:metabolism; D002460:Cell Line; D053595:Embryonic Stem Cells / Q000378:metabolism*; D005260:Female; D006801:Humans; D051379:Mice; D056918:Nuclear Receptor Coactivators / Q000378:metabolism*; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D014599:Uterus / Q000378:metabolism / Q000473:pathology
D051838:COUP Transcription Factor I; D051837:COUP Transcription Factor II; D056918:Nuclear Receptor Coactivators; D018160:Receptors, Cytoplasmic and Nuclear
Genesis. 2005 Feb;41(2):58-66
15682389
Exp Mol Med. 2009 Aug 31;41(8):525-37
19696553
Development. 2010 Mar;137(5):725-34
20147377
Cancer Cell. 2004 Apr;5(4):375-87
15093544
Mol Endocrinol. 2005 Sep;19(9):2299-308
15890675
Mol Endocrinol. 2010 Jan;24(1):1-10
19934345
Nucl Recept Signal. 2009;7:e002
19381305
PLoS Genet. 2007 Jun;3(6):e102
17590085
Nucleic Acids Res. 2005 Feb 24;33(4):e36
15731329
Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16351-6
16251273
Hum Mol Genet. 1999 Jan;8(1):129-35
9887341
Transgenic Res. 1999 Jun;8(3):215-21
10478491
Semin Cell Dev Biol. 2008 Apr;19(2):178-86
18280760
Mol Endocrinol. 2008 Oct;22(10):2215-28
18417735
Am J Med Genet C Semin Med Genet. 2007 May 15;145C(2):109-16
17436296
Nat Neurosci. 2008 Sep;11(9):1014-23
19160499
Mol Endocrinol. 2006 Jun;20(6):1248-60
16601069
Dev Biol. 2009 Feb 15;326(2):378-91
19041640
Cell. 1995 Dec 15;83(6):835-9
8521507
Cancer Res. 2005 Sep 1;65(17):7976-83
16140970
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3687-92
20133706
Science. 2008 Nov 28;322(5906):1395-9
19039140
Genes Dev. 1997 Aug 1;11(15):1925-37
9271116
Proc Natl Acad Sci U S A. 1989 Nov;86(22):8977-81
2510172
Cancer Cell. 2004 Sep;6(3):263-74
15380517
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8424-8
8378314
FEBS Lett. 2008 Jan 9;582(1):2-9
18023286
Endocr Rev. 2007 Aug;28(5):575-87
17609497
J Natl Cancer Inst. 2003 Mar 5;95(5):353-61
12618500
Nature. 2005 May 5;435(7038):98-104
15875024
BMC Biotechnol. 2009 Jan 14;9:3
19144171
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3789-94
9108056
Cell Metab. 2009 Jan 7;9(1):77-87
19117548
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5037-42
10220414
Cell. 1991 Feb 22;64(4):693-702
1997203
Nat Genet. 1997 Aug;16(4):391-6
9241280
Nat Genet. 1999 Jan;21(1):70-1
9916792
Mol Cell Biol. 1992 Sep;12(9):4153-63
1324415
Endocr Rev. 1997 Apr;18(2):229-40
9101138
Cell. 2006 Aug 25;126(4):801-10
16923398
J Neurosci. 2009 Oct 7;29(40):12401-11
19812316
Development. 2006 Sep;133(18):3683-93
16914494
Science. 1997 Aug 15;277(5328):965-8
9252329
FEBS Lett. 1997 May 5;407(3):313-9
9175875
Development. 2005 May;132(9):2179-89
15829524
Am J Med Genet. 2000 Dec 4;96(6):808-13
11121187
J Clin Invest. 1997 Jan 15;99(2):297-304
9005998
Curr Drug Metab. 2005 Aug;6(4):329-39
16101572